O

Onesource Specialty Pharma Ltd
NSE:ONESOURCE

Watchlist Manager
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
Watchlist
Price: 1 163.3 INR -18.79% Market Closed
Market Cap: ₹133.2B

Operating Margin

15.6%
Current
Improving
by 1.2%
vs 3-y average of 14.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.6%
=
Operating Income
₹1.9B
/
Revenue
₹12.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.6%
=
Operating Income
₹1.9B
/
Revenue
₹12.1B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
138.2B INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.1B USD
Loading...
US
Danaher Corp
NYSE:DHR
167.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.2B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
276.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20B EUR
Loading...

Market Distribution

Higher than 75% of companies in India
Percentile
75th
Based on 5 437 companies
75th percentile
15.6%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Onesource Specialty Pharma Ltd
Glance View

Onesource Specialty Pharma Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Bangalore, Karnataka and currently employs 525 full-time employees. The company went IPO on 2025-01-24. OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. The company operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The firm specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. The company supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The firm caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.

ONESOURCE Intrinsic Value
1 334.61 INR
Undervaluation 13%
Intrinsic Value
Price
O
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
15.6%
=
Operating Income
₹1.9B
/
Revenue
₹12.1B
What is Onesource Specialty Pharma Ltd's current Operating Margin?

The current Operating Margin for Onesource Specialty Pharma Ltd is 15.6%, which is above its 3-year median of 14.4%.

How has Operating Margin changed over time?

Over the last 4 months, Onesource Specialty Pharma Ltd’s Operating Margin has increased from 13.2% to 15.6%. During this period, it reached a low of 13.2% on Mar 3, 2025 and a high of 15.6% on Jul 30, 2025.

Back to Top